Table 1.
Clinical information for TCGA cohort.
| Characteristics | High (N = 151) |
Low (N = 153) |
Overall (N = 304) |
|---|---|---|---|
| Age | |||
| <60 | 73 (48.3%) | 74 (48.4%) | 147 (48.4%) |
| ≥60 | 78 (51.7%) | 79 (51.6%) | 157 (51.6%) |
| Gender | |||
| Female | 45 (29.8%) | 48 (31.4%) | 93 (30.6%) |
| Male | 106 (70.2%) | 105 (68.6%) | 211 (69.4%) |
| Histologic_grade | |||
| G1 | 16 (10.6%) | 27 (17.6%) | 43 (14.1%) |
| G2 | 66 (43.7%) | 79 (51.6%) | 145 (47.7%) |
| G3 | 61 (40.4%) | 43 (28.1%) | 104 (34.2%) |
| G4 | 8 (5.3%) | 4 (2.6%) | 12 (3.9%) |
| Pathologic_T stage | |||
| T1 | 57 (37.7%) | 95 (62.1%) | 152 (50.0%) |
| T2 | 44 (29.1%) | 30 (19.6%) | 74 (24.3%) |
| T3 | 43 (28.5%) | 25 (16.3%) | 68 (22.4%) |
| T4 | 7 (4.6%) | 3 (2.0%) | 10 (3.3%) |
| Pathologic_stage | |||
| Stage I | 56 (37.1%) | 95 (62.1%) | 151 (49.7%) |
| Stage II | 43 (28.5%) | 30 (19.6%) | 73 (24.0%) |
| Stage III | 50 (33.1%) | 28 (18.3%) | 78 (25.7%) |
| Stage IV | 2 (1.3%) | 0 (0%) | 2 (0.7%) |
| Cancer_status | |||
| Tumor free | 75 (49.7%) | 96 (62.7%) | 171 (56.3%) |
| With tumor | 76 (50.3%) | 57 (37.3%) | 133 (43.8%) |
| TMB | |||
| Average | 3.9 | 3.3 | 3.6 |